On the filings, Global Payments (GPN) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Cheap payments processor at 11.6x EPS, but mid-transformation with rising debt from the Worldpay deal and Issuer Solutions divestiture.
Sticky financial-services processor with strong cash flow, but weak GAAP earnings, real leverage and a scarred balance sheet keep it a hold near fair value.
| Metric | GPN | FIS |
|---|---|---|
| Fundamentals score | 61 | 58 |
| Revenue growth (YoY) | -0.4% | +5.4% |
| Net income growth (YoY) | -10.8% | -73.7% |
| Net margin | 18.2% | 3.6% |
| Return on equity | 6.1% | 2.7% |
| ROIC (est.) | 3.1% | 5.7% |
| Liabilities / Equity | 1.29 | 1.41 |
| Piotroski F-score | 4 / 9 | 6 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:42 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:41 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.